A conceptual scene connecting highly marketed processed food, an ordinary person using a glucose monitor, and the recurring treatment economy, with a small frog and piggy bank tucked into the scene.

An evidence-based investigation

Profitable food. Preventable disease. Lifelong treatment.

What if the diabetes epidemic is working exactly as the system rewards?

Not because anyone planned it—but because the incentives behind profitable food, chronic disease and recurring treatment may reinforce one another.

23 cited sourcesTechnical evidence reportRelated scholarly researchAdversarial AI review

The argument in 30 seconds

Follow the incentives—not a conspiracy.

The biological causes of type 2 diabetes are real. This investigation asks a different question: why does the surrounding economic system keep producing the conditions that make the disease so prevalent?

01

Profitable exposure

Growth rewards inexpensive, convenient and heavily marketed food engineered for frequent consumption.

02

Population-level disease

That environment makes damaging dietary patterns easier, more normal and more persistent across millions of lives.

03

Profitable treatment

Type 2 diabetes then creates durable demand for medication, monitoring, appointments and lifelong management.

The thesis is not that disease was planned. It is that the system can reward the conditions that produce it—and then reward managing the result.

The line we draw

What this investigation concludes—and what it does not.

Provocative claims deserve precise boundaries. These distinctions are central to the argument, not fine print added afterward.

Professor Hoot, a scholarly gray owl wearing round glasses and pointing toward the evidence with a pointer.
Professor Hoot — The Evidence Owl
The investigation arguesIt does not allege
Corporate incentives materially shape the food environment.That a coordinated conspiracy created the diabetes epidemic.
That environment increases type 2 diabetes risk across populations.That corporations directly cause every individual case.
Chronic disease produces substantial recurring revenue.That doctors want patients to remain sick.
The systems can reinforce an unhealthy equilibrium.That every company or participant behaves identically.

Choose how deeply to investigate

Start with the question. Go as deep as you choose.

The same thesis is presented at three levels, so accessibility never has to come at the expense of rigor.

01

Read the investigation

The complete argument in clear, accessible language.

A reader-first account of how the incentives connect, written without requiring specialist knowledge.

Begin with the public article
02

Examine the evidence

The technical report, causal reasoning and 23 cited sources.

The full causal analysis, evidentiary boundaries, confidence judgments and source-by-source foundation.

Open the evidence report
03

Explore related research

The scholarship this investigation builds upon—and extends.

A guide to the established fields and publications that align with—and help test—the original synthesis.

Review the scholarship

How the argument was tested

Built to survive disagreement.

The final work separates established findings from analytical synthesis. Multiple AI models were used to challenge the reasoning, surface counterarguments and detect overstatement—not as authorities, but as adversarial reviewers.

  • 01Primary and scholarly sources anchor the factual links.
  • 02Evidence, inference and author-assigned confidence are identified separately.
  • 03Counterarguments and plausible alternative explanations are addressed directly.
  • 04Qualifications produced by review were incorporated into the final articles.
Read the human–AI collaboration case study

The bigger picture

The lightbulb moment.

At first, this appears to be a story about diabetes.

Then you notice the same pattern elsewhere.

Food companies profit from increased consumption. Healthcare corporations profit from increased treatment. Social-media platforms profit from increased engagement. Gambling companies profit from continued betting. News organizations profit from continued attention.

Different industries. Different products. Different forms of harm.

But underneath them is the same corporate selection system.

The people who most successfully produce revenue, profit and growth acquire greater authority. Those who fail to deliver the required financial results are replaced.

Once you see that mechanism, the apparently separate problems begin to look connected.

The product changes. The incentive structure remains.

Diagram showing how the corporate structure selects for growth, revenue and engagement across food, healthcare, social media, news, gambling and AI.

The question behind the question

Diet contributes to type 2 diabetes. But why does the system keep producing the conditions that make it so prevalent?

That is the investigation.